Position in ABBV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$2,578,303
+$416,453 QoQ
Shares Held
10,246
+3.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#1,756
of 4,153 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clear Creek Financial Management, LLC holds $18,746,377 across 11 Drug Manufacturers - General names. ABBV ranks #3 (13.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,281 | $5,134,760 | |
| 2 | JNJ |
Johnson & Johnson
|
10,174 | $2,583,890 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
10,246 | $2,578,303 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
15,209 | $1,921,505 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,408 | $1,465,928 | |
| 6 | NVO |
Novo Nordisk A S
|
28,506 | $1,366,577 | |
| 7 | NVS |
Novartis AG
|
8,250 | $1,292,940 | |
| 8 | AZN |
Astrazeneca PLC
|
6,227 | $1,180,763 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,578,303 | 10,246 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $2,161,850 | 9,940 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $1,259,208 | 5,511 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $995,158 | 4,298 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $811,901 | 4,374 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $918,535 | 4,384 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $693,740 | 3,904 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $664,915 | 3,367 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $572,876 | 3,340 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $567,787 | 3,118 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $395,948 | 2,555 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $438,534 | 2,942 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $351,510 | 2,609 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $462,491 | 2,902 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $474,486 | 2,936 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $349,751 | 2,606 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $452,894 | 2,957 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $605,318 | 3,734 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $474,035 | 3,501 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $387,900 | 3,596 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $407,869 | 3,621 | Shares | Sole | 2021-07-30 | |
| 2020-12-31 | $441,886 | 4,124 | Shares | Sole | 2021-02-12 | |
| 2020-06-30 | $290,907 | 2,963 | Shares | Sole | 2020-07-16 | |
| No filing history on record for this holder in this stock. | ||||||